Upcoming Event on Orphan Drugs and Rare Diseases– | 14th – 15th October 2024
Join us at our MarketsandMarkets 5th Annual Orphan Drugs and Rare Diseases Conference in Germany, Europe, for a groundbreaking exploration of the recent advances in developing life-saving therapies, technologies in diagnosing, and strategies to enhance orphan drug development.\n\nEnquire Now @ https
1 views • 5 slides
Overview of Poultry Diseases and their Causes
Poultry diseases caused by viruses and bacteria are a significant concern for poultry farmers. Viral diseases like Ranikhet Disease, Fowl Pox, and Avian Leucosis can have high mortality rates and severe symptoms. Bacterial diseases such as Tick Fever, Tuberculosis, Fowl Cholera, and Infectious Coryz
2 views • 12 slides
Rare Isotope Beams from FRIB - Facility Overview and Operations
FRIB (Facility for Rare Isotope Beams) is supported by the U.S. Department of Energy and Michigan State University. It utilizes advanced techniques for rare isotope beam formation, offering insights into nuclear physics. The facility operates with high beam power, serving various scientific experime
0 views • 15 slides
Best Neurosurgery Hospitals in India
Neuro diseases are very bad diseases. Many people are caught by Neuro diseases nowadays. It is related to brain diseases. Many people in India are caught by Neuro Diseases. It happens in Adults as well as children.\nA person of any age can be affected by this. Before this time very bad disease Named
1 views • 2 slides
Orphan Drugs and Rare Diseases – US Edition | 17th - 18th October 2024
Join us at our MarketsandMarkets Orphan Drugs and Rare Diseases Conference in Boston, USA for a groundbreaking exploration of the recent advances in developing life-saving therapies, technologies in diagnosing, and strategies to enhance orphan drug development.\n\nRegister Now @ \/\/events.marketsan
1 views • 5 slides
Occupational Exposure to Hazardous Drugs: Risks and Prevention
Learn about the hazards of exposure to hazardous drugs, including potential health risks such as cancer, nausea, reproductive toxicity, and organ damage. Explore training modules, drug categories, and a list of hazardous drugs to ensure workplace safety. Discover NIOSH criteria for identifying hazar
1 views • 42 slides
Overview of Drugs and Cosmetics Act, 1940
The Drugs and Cosmetics Act of 1940 was enacted to regulate the import, manufacture, distribution, and sale of drugs and cosmetics in India. The Act aims to ensure high standards of medical treatment, prevent substandard drugs, and establish advisory boards for different types of drugs. It sets out
0 views • 49 slides
Concerns Over Weight Loss Drugs and Rare Eye Condition
Novo Nordisk shares remained stable on Thursday, despite a critical report from Harvard Medical School linking the company\u2019s weight loss drugs to a rare eye condition
0 views • 2 slides
Sources of Crude Drugs: Plant, Animal, Marine, and Tissue Culture in Pharmacognosy
Crude drugs are natural substances obtained from plants, animals, and minerals. They are used without much processing and have therapeutic properties. Different plant parts like leaves, flowers, fruits, seeds, roots, bark, and stems yield various important drugs. Animals and minerals also serve as s
1 views • 19 slides
Palak Mata Pita Yojana in Gujarat - Providing Financial Assistance to Orphan Children
The Palak Mata Pita Yojana in Gujarat provides financial assistance to orphan children aged 0-18 years. Started in 1978, the scheme aims to offer a domestic environment for orphan children, with financial assistance increasing over the years. Foster parents must meet income criteria, and specific do
0 views • 12 slides
Understanding Fungal and Protist Diseases: Impacts and Prevention
Fungi and protists play significant roles as pathogens, causing diseases in both humans and plants. Fungal diseases like athletes foot and protist diseases like malaria can have serious impacts on health. Control measures such as understanding symptoms, spread mechanisms, and prevention strategies a
0 views • 10 slides
The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 Overview
The Drugs and Magic Remedies (Objectionable Advertisements) Act of 1954 regulates the advertising of drugs and remedies claiming magical properties in India. It defines drugs and magic remedies, prohibits certain types of advertisements related to drugs, and aims to control misleading marketing prac
0 views • 12 slides
Overview of Drugs and Cosmetics Act, 1940 and Its Rules 1945
The Drugs and Cosmetics Act of 1940 and its Rules of 1945 were established to regulate the import, manufacture, distribution, and sale of drugs and cosmetics in India. The Act ensures that only qualified individuals are involved in these processes and aims to prevent the entry of substandard or spur
0 views • 116 slides
Overview of Anxiety Disorders and Antianxiety Drugs
Anxiety disorders are conditions characterized by excessive worry and fear that can interfere with daily life. Common types include generalized anxiety disorder, panic disorder, phobias, and OCD. Treatment options include psychotherapy and anxiolytic drugs such as benzodiazepines, 5HT1A agonists, be
0 views • 25 slides
Overview of Anticestodal Drugs in Veterinary Pharmacology
Anticestodal drugs play a crucial role in combating tapeworm infections in veterinary medicine. These drugs are classified into taeniafuges and taenicides, with examples of natural and synthetic compounds highlighted. Natural compounds like pumpkin seeds and male fern are traditionally used for thei
0 views • 29 slides
Overview of Central Drug Standard Control Organisation (CDSCO) in India
The Central Drug Standard Control Organisation (CDSCO) is the main regulatory body in India for pharmaceuticals, medical devices, and clinical trials. It functions under the Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. The CDSCO is responsible f
0 views • 18 slides
Understanding Generic Drugs and Brand Name Medications
Generic drugs are identical copies of brand-name medications in dosage, strength, quality, and intended use. They contain the same active ingredients but are sold under their chemical name. This article explores the basic differences between generic and brand-name drugs, when generic drugs are marke
0 views • 20 slides
Updates on European Training Requirements for Rare Diseases and Neuroendocrine Neoplasia Medicine
Comprehensive updates on European training requirements for rare diseases, rare adult solid cancers, and neuroendocrine neoplasia medicine. Initiatives include syllabi, competencies, and collaborations with international networks for advancements in the field.
0 views • 6 slides
Overview of Antitubercular Drugs: Introduction, Classification, and Applications
Tuberculosis is a chronic granulomatous disease caused by Mycobacterium bovis in ruminants and Mycobacterium avium in dogs and pigs. These bacteria have a unique waxy appearance due to their cell wall composition, providing a shield against pharmacological compounds. Antitubercular drugs play a cruc
3 views • 28 slides
Stakeholder Engagement in Rare Diseases: Key Role in Ghana
Rare diseases in Ghana present significant challenges such as lack of awareness, insufficient data, delayed diagnosis, and limited treatment options. To address these issues, collaborative efforts involving multiple stakeholders are essential. Actions are needed to enhance health education, improve
0 views • 9 slides
Advances in Antimicrobial Drugs: Selective Toxicity and Classification
The development of antimicrobial drugs has significantly improved therapeutics by controlling infections and preventing complications. These drugs target invading microorganisms using selective toxicity, sparing host cells. Antimicrobial drugs are classified based on site, mechanism of action, and c
0 views • 30 slides
Classification of Drugs Acting on Central Nervous System
The Central Nervous System (CNS) plays a crucial role in coordinating the body's functions and responses to the environment. Drugs acting on the CNS can be classified into CNS stimulants and CNS depressants. CNS stimulants include spinal, medullary, and cortical stimulants, with various direct and i
0 views • 10 slides
Zoonotic Diseases in Mongolia: A One Health Perspective
High risk of zoonosis in Mongolia is evident due to various factors such as livestock practices, wildlife diseases, and environmental changes. The National Center for Zoonotic Diseases in Mongolia plays a crucial role in studying, preventing, and raising awareness about over 160 zoonotic infectious
0 views • 13 slides
EveryLife Foundation for Rare Diseases Introductory Webinar Overview
The EveryLife Foundation for Rare Diseases held an introductory webinar providing insights into their mission, foundation overview, staff members, board composition, and initiatives like advocating for biotechnology innovation and rare disease treatments through policy and law changes. The foundatio
0 views • 31 slides
BURQOL-RD Project: Analyzing Rare Diseases' Impact in Europe
BURQOL-RD is a 3-year project under the European community's action program, focusing on measuring the socio-economic burden and health-related quality of life of patients with rare diseases in Europe. The project aims to develop tools to assess the impact of national policies and create a model ada
0 views • 19 slides
Managing for Multiple Values in Forest Conservation
Forest management for multiple values involves producing timber, providing recreation, protecting watersheds, and perpetuating rare species. Covering over 11,000 acres with a diverse ecosystem, the area includes oak woodlands, savannas, and prairies. With a shift towards conserving rare features and
0 views • 17 slides
Pharmacology of Ovulation-Inducing Drugs
Understanding the mechanism of ovulation and hormonal regulation is key in classifying drugs used to induce ovulation. This lecture covers the pharmacology of different groups of drugs, their mechanisms of action, administration protocols, indications, efficacy rates, and adverse effects. Antiestrog
0 views • 6 slides
Introduction to Practical Pharmacognosy: Study of Medicines from Natural Sources
Pharmacognosy is the study of medicines derived from natural sources, exploring drugs from plants through the lenses of botany, chemistry, and pharmacology. This includes the classification of vegetable drugs based on taxonomic, chemical, and morphological characteristics. Understanding key points f
0 views • 19 slides
Update on BSEE Program and Action Plan for Orphan Assets
Advisory updates on BSEE program focusing on bankruptcies, orphan assets, and decommissioning liabilities. Actions include contracting procedures, financial assurance coverage, and funding strategies to address wells, pipelines, and structures. Attention given to MIGO, ANGLO SUISSE, and ATP/BENNU as
0 views • 22 slides
Understanding the Impact of Drugs on Pregnancy Development
This lecture covers factors influencing placental transfer, harmful effects of drugs at different developmental stages, FDA classifications of drugs, and teratogenic drugs. It explains how drugs cross the placenta, including physiochemical properties and stage of development affecting transfer. The
0 views • 10 slides
Analyzing Clinical Trial Results for Rare Diseases: Challenges, Highlights & Missing Data
This analysis delves into the challenges, strengths, weaknesses, and missing data in a clinical trial study focusing on rare diseases. It critiques aspects such as recruitment, study design, surrogate markers, and statistical analysis, offering valuable insights for interpreting clinical trial resul
0 views • 12 slides
The Forgotten Side of DNS: Orphan and Abandoned Records
DNS zone administration can be complex, leading to misconfigurations like orphan and abandoned records. Orphan records are former glue records no longer needed, while abandoned records have related domains but are unnecessary. This analysis extends prior research, examining 2K TLDs over 25 months to
0 views • 19 slides
Understanding Prion Diseases: A Comprehensive Overview
Prion diseases, such as Transmissible Spongiform Encephalopathies (TSEs), are rare and fatal neurological disorders affecting both humans and animals. These diseases are characterized by long incubation periods, neuronal loss, and the absence of an inflammatory response. Caused by abnormal folding o
0 views • 12 slides
Challenges in Ensuring Critical Mineral Supply for Japan's Sustainable Industrial Activities
Japan faces challenges in securing critical minerals for sustainable industrial activities due to market failures in rare metals trade, lack of information symmetry in supply chains, and the small market size of rare metals. The Government of Japan implements policy measures such as overseas resourc
0 views • 15 slides
Advancing Rare Disease Research and Healthcare Initiatives
This presentation highlights the objectives, thematic priorities, and actions of the RD-ACTION project funded by the European Union's Health Programme. It focuses on supporting the Orphanet database, promoting multi-stakeholder debates on rare diseases, and enhancing data sharing and healthcare path
0 views • 16 slides
Addressing the Rare Word Problem in Neural Machine Translation
Thang Luong and team addressed the rare word problem in Neural Machine Translation by proposing an approach to track the origins of rare words in target sentences. They utilized unsupervised alignments and relative indices in the training data and implemented a post-processing method for test transl
0 views • 21 slides
Understanding the Drugs and Magic Remedies Act 1954
The Drugs and Magic Remedies Act 1954 regulates the advertisement of drugs and prohibits the promotion of remedies claiming magical qualities. It defines various terms related to drugs and advertisements, while emphasizing the need for ethical and truthful advertising to protect the public. The Act
0 views • 26 slides
Practical Guidelines for Designing Clinical Trials in Rare Diseases
This comprehensive content delves into the strategic planning of clinical trials for rare diseases, emphasizing the utilization of historical control data and the challenges associated with it. It discusses the significance of historical control in trial design, the evolving landscape of rare diseas
0 views • 18 slides
Enhancing Word Representation for Rare Words by Xiao Wenyi
This article discusses methods for improving word representation for rare words, such as the count-based Skip-gram by Mikolov and the predict-based GloVe by Pennington. It explores the concepts of Skip-gram, GloVe, and issues faced by existing models in handling rare words.
0 views • 22 slides
Overview of Pharmacognosy and Natural Products
Pharmacognosy is the study of medicinal drugs derived from natural sources, focusing on the properties and origins of crude drugs like plants and animals. The term was coined in 1815, emphasizing knowledge of drugs' physical, chemical, and biological properties. It is associated with various branche
0 views • 18 slides